KR20240042402A - 경구 이뇨제에 불응성인 부종을 치료하기 위한 피하 제제 및 방법 - Google Patents
경구 이뇨제에 불응성인 부종을 치료하기 위한 피하 제제 및 방법 Download PDFInfo
- Publication number
- KR20240042402A KR20240042402A KR1020247000323A KR20247000323A KR20240042402A KR 20240042402 A KR20240042402 A KR 20240042402A KR 1020247000323 A KR1020247000323 A KR 1020247000323A KR 20247000323 A KR20247000323 A KR 20247000323A KR 20240042402 A KR20240042402 A KR 20240042402A
- Authority
- KR
- South Korea
- Prior art keywords
- bumetanide
- pharmaceutical composition
- subject
- salt
- arginine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163208863P | 2021-06-09 | 2021-06-09 | |
| US63/208,863 | 2021-06-09 | ||
| PCT/US2022/032862 WO2022261344A1 (en) | 2021-06-09 | 2022-06-09 | Subcutaneous formulation and methods for treating edema refractory to oral diuretics |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20240042402A true KR20240042402A (ko) | 2024-04-02 |
Family
ID=84425561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020247000323A Pending KR20240042402A (ko) | 2021-06-09 | 2022-06-09 | 경구 이뇨제에 불응성인 부종을 치료하기 위한 피하 제제 및 방법 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240285566A1 (https=) |
| EP (1) | EP4351554A4 (https=) |
| JP (1) | JP2024520788A (https=) |
| KR (1) | KR20240042402A (https=) |
| CN (1) | CN117915905A (https=) |
| AU (1) | AU2022289724A1 (https=) |
| BR (1) | BR112023025880A2 (https=) |
| CA (1) | CA3221710A1 (https=) |
| IL (1) | IL309160A (https=) |
| WO (1) | WO2022261344A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL293429A (en) | 2019-12-04 | 2022-07-01 | RESQ Pharmaceuticals LLC | Methods and preparations for the treatment of edema resistant to oral diuretics |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040105818A1 (en) * | 2002-11-26 | 2004-06-03 | Alexza Molecular Delivery Corporation | Diuretic aerosols and methods of making and using them |
| US7906555B2 (en) * | 2006-10-26 | 2011-03-15 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance |
| US20140128469A1 (en) * | 2011-05-10 | 2014-05-08 | Concert Pharmaceuticals Inc. | Deuterated n-butyl bumetanide |
| US20210163406A1 (en) * | 2018-04-06 | 2021-06-03 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Bumetanide Derivatives for the Therapy of Stroke and Other Neurological Diseases/Disorders Involving NKCCs |
| IL293429A (en) * | 2019-12-04 | 2022-07-01 | RESQ Pharmaceuticals LLC | Methods and preparations for the treatment of edema resistant to oral diuretics |
-
2022
- 2022-06-09 JP JP2023575713A patent/JP2024520788A/ja active Pending
- 2022-06-09 EP EP22821041.5A patent/EP4351554A4/en active Pending
- 2022-06-09 CA CA3221710A patent/CA3221710A1/en active Pending
- 2022-06-09 IL IL309160A patent/IL309160A/en unknown
- 2022-06-09 KR KR1020247000323A patent/KR20240042402A/ko active Pending
- 2022-06-09 BR BR112023025880A patent/BR112023025880A2/pt not_active Application Discontinuation
- 2022-06-09 CN CN202280053609.8A patent/CN117915905A/zh active Pending
- 2022-06-09 AU AU2022289724A patent/AU2022289724A1/en active Pending
- 2022-06-09 US US18/568,440 patent/US20240285566A1/en active Pending
- 2022-06-09 WO PCT/US2022/032862 patent/WO2022261344A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| BR112023025880A2 (pt) | 2024-02-27 |
| IL309160A (en) | 2024-02-01 |
| CA3221710A1 (en) | 2022-12-15 |
| WO2022261344A1 (en) | 2022-12-15 |
| EP4351554A4 (en) | 2025-05-07 |
| AU2022289724A1 (en) | 2024-01-18 |
| JP2024520788A (ja) | 2024-05-24 |
| US20240285566A1 (en) | 2024-08-29 |
| EP4351554A1 (en) | 2024-04-17 |
| CN117915905A (zh) | 2024-04-19 |
| WO2022261344A8 (en) | 2023-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12558330B2 (en) | Methods and compositions for treating edema refractory to oral diuretics | |
| JP7048576B2 (ja) | 酸素化コレステロールサルフェート、並びにポリアルキレングリコール、カルボキシメチルセルロース、及びポリオキシルグリセリドのうち少なくとも1種を含む組成物 | |
| TWI815796B (zh) | 包含5-膽甾烯-3,25-二醇3-硫酸酯(25hc3s)或其醫藥上可接受之鹽及至少一種環狀寡醣的組成物,以及使用彼等之方法 | |
| US20120040970A1 (en) | Intranasal delivery system for dantrolene | |
| BR112019014712A2 (pt) | Tratamento médio que compreende a administração entérica de edaravona | |
| KR20240042402A (ko) | 경구 이뇨제에 불응성인 부종을 치료하기 위한 피하 제제 및 방법 | |
| JP2023533129A (ja) | 非プロトン性極性溶媒中の安定な持続放出治療組成物およびその製造方法 | |
| CN1997383B (zh) | 含水母发光蛋白的组合物及使用它的方法 | |
| ES2396502T3 (es) | Formulaciones para la administración terapéutica de la hormona estimulante de la tiroides (TSH) | |
| AU2022311443A1 (en) | Aqueous bumetanide-containing liquid | |
| JPS63303931A (ja) | 経鼻投与用成長ホルモン放出活性物質製剤 | |
| HK40080175A (en) | Methods and compositions for treating edema refractory to oral diuretics | |
| US10201552B2 (en) | Method of increasing the bioavailability of an HIV drug | |
| Ichai et al. | Sodium disorders | |
| CN120713836A (zh) | 一种尼莫地平注射液及其制备方法 | |
| HK1208372A1 (en) | Liquid formulation | |
| HK1208372B (en) | Liquid formulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application | ||
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20250609 Comment text: Request for Examination of Application |